Global Drug Device Combination Products Market 2015-2019 with Abbott Laboratories, Becton, Dickinson and Company, Boston Scientific, Medtronic & Roche Diagnostics Dominating

DUBLIN, November 25, 2015 /PRNewswire/ --

Research and Markets(http://www.researchandmarkets.com/research/kcwjb6/global_drug) has announced the addition of the"Global Drug Device Combination Products Market 2015-2019" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

The report forecasts the global drug device combination products market to grow at a CAGR of 11.95% over the period 2014-2019.

Global Drug Device Combination Products Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global drug device combination products market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

One of the major trend is the use of bioabsorbable stents for treating arterial blockages. These stents have the ability to dissolve completely, over the course of time, by the formation of human cells around them. Other trends witnessed by the market are an increase in online marketing services and the growing popularity of hybrid procedures.

According to the report, use of home healthcare devices will be one of the major drivers contributing to market growth during the forecast period. The shift of patient care from hospital settings toward homecare, especially for the elderly population, is rising gradually. This is fueled by an increase in the geriatric population, older people being prone to respiratory and cardiovascular diseases. This factor will contribute to market growth largely.

Further, the report states that one of the major challenges faced by the market is continuous spending by patients for therapy, which reduces the adoption of drug device combination products by consumers in homecare settings and therefore customers such as diagnostic centers.

The market can be segmented by product type:

• Drug eluting stent
• Prefilled syringes
• Wearable injectors
• Insulin delivery systems

Key vendors

• Abbott Laboratories
• Becton, Dickinson and Company
• Boston Scientific
• Medtronic
• Roche Diagnostics

Key Topics Covered:

Part 01: Executive summary

Part 02: Scope of the report

Part 03: Market research methodology

Part 04: Introduction

Part 05: Market landscape

Part 06: Market segmentation by product

Part 07: Geographical segmentation

Part 08: Market drivers

Part 09: Impact of drivers

Part 10: Market challenges

Part 11: Impact of drivers and challenges

Part 12: Market trends

Part 13: Vendor landscape

Part 14: Key vendor analysis

Part 15: Appendix

For more information visithttp://www.researchandmarkets.com/research/kcwjb6/global_drug

Media Contact:
Laura Wood
[phone]
[e-mail]